Results 191 to 200 of about 209,031 (375)

Real‐life implementation of guideline‐recommended medical therapy in heart failure with reduced ejection fraction: Effects on prognosis and left ventricular ejection fraction. Primary results of TITRATE‐HF

European Journal of Heart Failure, EarlyView.
Primary results of TITRATE‐HF. GRMT, guideline‐recommended medical therapy; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction. Abstract Aims Guideline‐recommended medical therapy (GRMT) improves outcomes in heart failure (HF) with reduced ejection fraction (HFrEF), yet implementation ...
Jishnu Malgie, Mariëlle I. Wilde, Stefan Koudstaal, Robert Denham, Carlos A. da Fonseca, Henk P. Swart, Clara E.E. van Ofwegen, Ayten Yilmaz, Ron Pisters, Gerard C.M. Linssen, Nikola Faber, Loek van Heerebeek, Julio E.C. van de Swaluw, Rudolf A. de Boer, Hans‐Peter Brunner‐La Rocca, Jasper J. Brugts   +15 more
wiley   +1 more source

Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation [PDF]

, 2017
Aims To investigate the effects of cardiac resynchronization therapy (CRT) on survival in heart failure (HF) patients with permanent atrial fibrillation (AF) and the role of atrio-ventricular junction (AVJ) ablation in these patients. Methods and results
Auricchio, Angelo, Curnis, Antonio, Fantoni, Cecilia, Gasparini, Maurizio, Klersy, Catherine, Lamp, Barbara, Metra, Marco, Regoli, François, Vogt, Juergen   +8 more
core  

Cardiac rehabilitation in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator

, 2022
Damir Raljević, Lovro Bebić, Sanja Rončević, Vesna Pehar Pejčinović, Dijana Travica Samsa, Viktor Peršić   +5 more
openalex   +1 more source

Nationwide implementation of heart failure therapies: National Heart Failure Center Accreditation Program (HF‐CAP) in China

European Journal of Heart Failure, EarlyView.
Nationwide implementation of heart failure therapies in China. ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNI, angiotensin receptor–neprilysin inhibitor; CI, confidence interval; CV, cardiovascular; GDMT, guideline‐directed medical therapy; HF, heart failure; HF‐CAP, National Heart Failure Center Accreditation ...
Jingmin Zhou, Xuejuan Jin, Yamei Xu, Zhonglei Xie, Xiaotong Cui, Yanyan Wang, Hua Wang, Xinli Li, Yugang Dong, Yuhua Liao, Weimin Li, Alexandre Mebazaa, Jiefu Yang, Junbo Ge, on behalf of the Heart Failure Center Accreditation Program Investigators   +14 more
wiley   +1 more source

136-48: Unfavourable outcome after the upgrade of an implantable cardioverter defibrillator to cardiac resynchronization therapy [PDF]

, 2016
Alexandra Kiss, Gábor Sándorfi, István Édes, Zoltán Csanádi, Marcell Clemens   +4 more
openalex   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

European Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis, Marianna Adamo, Volker Rudolph, Nicole Karam, Ralph Stephan von Bardeleben, Stefan D. Anker, Victoria Delgado, Jörg Hausleiter, Hannah Kempton, Marco Metra, Michael Böhm, Stephan Baldus   +11 more
wiley   +1 more source

Cystatin C as a Predictor of Mortality and Cardiovascular Morbidity After Cardiac Resynchronization Therapy

, 2013
Toshihiko Yamamoto, Masayuki Shimano, Yasuya Inden, Shinjiro Miyata, Yoko Inoue, Naoki Yoshida, Yukiomi Tsuji, Makoto Hirai, Toyoaki Murohara   +8 more
openalex   +2 more sources

Endo-Epicardial ablation of incessant slow monomorphic ventricular tachycardia originating from the left ventricular summit in a patient with cardiac resynchronization therapy defibrillator [PDF]

, 2023
Ivan Alejandro Elizalde-Uribe, Elias Noel Andrade-Cuellar, Rogelio Robledo‐Nolasco, Julieta D. Morales-Portano, Carlos Manrriquez-Trasviña, Felipe Israel López-Trejo, Ariel Alberto Figueroa-Zelaya, Jorge A. Lara-Vargas, Gerardo Rodríguez-Diez, Martín Ortiz-Ávalos, Enrique Gómez-Álvarez   +10 more
openalex   +1 more source

Beta‐blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

European Journal of Heart Failure, EarlyView.
In total, 5084 patients from Swedish registries with both heart failure (HF) with reduced ejection fraction (HFrEF) and chronic obstructive pulmonary disease (COPD) were included. Confounding was handled by overlap weighting based on propensity scores for beta‐blocker use. Patients were followed up for 5 years, or until death, emigration from Sweden or
Benedikt N. Beer, Lina Benson, Christian Basile, Benedikt Schrage, Peter Moritz Becher, Stefan Blankenberg, Paulus Kirchhof, Barna Szabó‐Söderberg, Marco Metra, Anne Lindberg, Egidio Imbalzano, Giuseppe M. C. Rosano, Patric Karlström, Peter G.M. Mol, Raffaele Scorza, Lars H. Lund, Felix Lindberg, Gianluigi Savarese   +17 more
wiley   +1 more source

Healthcare system deficiencies should never be employed as justification for delivering sub‐standard care to heart failure patients. Letter regarding the article ‘Serial assessment of left ventricular ejection fraction for the management of heart failure: Unnecessary and unrealistic?’

European Journal of Heart Failure, EarlyView.
Giuseppe M.C. Rosano, Antoni Bayes‐Genis, Koichiro Kinugawa, John R. Teerlink, Marco Metra, Andrew J.S. Coats   +5 more
wiley   +1 more source